Tag: Occupational Hazards

ACS, ASA, AORN call for centralized, coordinated governmental action for COVID-19

Editor's Note In a November 23 letter to federal government leaders, the American College of Surgeons (ACS), American Society of Anesthesiologists (ASA), and Association of periOperative Registered Nurses (AORN) asked officials “to act collectively and quickly in support of hospitals and healthcare providers as they continue to struggle in response…

Read More

By: Judy Mathias
November 30, 2020
Share

Danish study: Effectiveness of masks in preventing COVID-19

Editor's Note This Danish unblinded, randomized, controlled trial finds that wearing masks to supplement other public health measures did not reduce the COVID-19 infection rate among wearers. Researchers randomized 3,030 participants to wear three-layer, disposable surgical masks with ear loops that were made in China, and 2,994 were assigned to…

Read More

By: Judy Mathias
November 19, 2020
Share

FDA authorizes first home test for COVID-19

Editor's Note The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home. The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report…

Read More

By: Judy Mathias
November 19, 2020
Share

Marine study shows COVID-19 transmission despite public health measures, strict quarantine

Editor's Note This study of 1,848 US Marine Corps recruits finds that despite social distancing, wearing masks, regular handwashing, and other public health measures including strict quarantine, recruits contracted COVID-19 and spread it to others, even though hardly any of them had symptoms. Study participants were told to isolate themselves…

Read More

By: Judy Mathias
November 18, 2020
Share

Pfizer, BioNTech COVID-19 vaccine 95% effective in final analysis, will seek EUA within days

Editor's Note Just a week after Pfizer revealed an interim analysis showing its COVID-19 vaccine to be more than 90% effective, the company on November 18 released its final efficacy analysis showing the vaccine is 95% effective, and that it protects older people who are most at risk of dying…

Read More

By: Judy Mathias
November 18, 2020
Share

Hospitals understaffed for COVID-19 surge

Editor's Note Demand for temporary nursing staff is on the rise as COVID-19 cases surge across the country, the November 13 Healthcare Dive reports. Surge capacity plans include the following: Utah-based Intermountain Healthcare is hiring 200 traveling nurses. The 24-hospital system also brought on 31 nurses from New York-Presbyterian, a…

Read More

By: Judy Mathias
November 17, 2020
Share

Nurses’ union survey reveals lack of preparation for COVID-19, flu season

Editor's Note A new nationwide survey by National Nurses United of more than 15,000 RNs finds that hospitals are failing to prepare for a surge of COVID-19 during flu season. Among the nurses’ complaints: inappropriate pursuit of profits resulting in lack of proper infection control measures ongoing issues of both…

Read More

By: Judy Mathias
November 17, 2020
Share

Editorial

Most respondents to a July 2020 American Organization for Nursing Leadership survey said they felt prepared for a future surge of COVID-19. That future is now, with nearly 150,000 new cases being reported daily across the country and multiple hospitals at capacity. Survey respondents said their biggest challenges early in…

Read More

By: Elizabeth Wood
November 17, 2020
Share

CDC: Impact of COVID-19 stress on children’s mental health

Editor's Note The number of children’s mental health emergency department (ED) visits decreased sharply from mid-March through early April 2020, coincident with the implementation of community mitigation measures enacted to prevent COVID-19 transmission, and then visits increased steadily through October, this study from the Centers for Disease Control and Prevention…

Read More

By: Judy Mathias
November 16, 2020
Share

Moderna announces 94.5% efficacy for COVID-19 vaccine

Editor's Note Moderna Inc (Cambridge, Massachusetts) on November 16 announced that its vaccine is 94.5% effective at preventing COVID-19. Their analysis of a 30,000-person trial (half received the vaccine and half received a placebo) finds that 90 of the 95 COVID-19 documented cases are in the placebo group. The Moderna announcement…

Read More

By: Judy Mathias
November 16, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat